Gerson Dierley Keppeke, PhD, Post-Doc - University of Oxford. Currently: Associate Professor, Departamento de Ciencias Biomedicas, Facultad de Medicina, Universidad Catolica del Norte, Coquimbo, Chile. As an Associate Professor at Universidad Católica del Norte and a Young Investigator at the Federal University of São Paulo, my research is dedicated to advancing our understanding of autoimmune diseases. My work focuses on the use of CRISPR gene editing to eliminate pathogenic autoantibodies and developing novel assays for detecting autoantibody biomarkers. This dual approach aims to both treat and diagnose autoimmune conditions more effectively. My academic journey includes a Ph.D. in Health Sciences applied to Rheumatology from UNIFESP, with a postdoctoral tenure at the University of Oxford, specializing in cellular and molecular biology and functional genomics. Over the years, I have published 26 papers, with 19 as first or shared first author, and have been cited nearly 600 times according to Google Scholar, reflecting the impact and recognition of my work in the scientific community. What sets my research apart is the innovative use of gene editing technologies and the focus on translating these findings into clinical applications. This not only contributes to the scientific understanding of autoimmunity but also holds the potential for developing new therapeutic and diagnostic tools that can significantly improve patient outcomes. I have made significant contributions to the field of rheumatology and autoimmunity. I have published 26 peer-reviewed articles, with 19 as the first or corresponding author, demonstrating my leadership in research projects. My work has been presented at 22 international academic conferences, reflecting my active engagement with the global scientific community. My research has been recognized with 592 citations on Google Scholar, giving me an H-index of 14. On SCOPUS, my work has garnered 446 citations, resulting in an H-index of 13. These metrics highlight the impact and relevance of my research within the scientific community. I have been honored with several awards, including the Prize Prof. Dr. Wiliam Habib Chahade (2020) for best poster presentation at the 26th Advanced Rheumatology meeting, the IWAA Prize (3rd place, 2014), the Dresden Prize for the Study on Autoantibodies (2013), and best poster at the XXIX Brazilian Congress of Rheumatology (2012). I have significantly contributed to the academic community through my role as a peer reviewer. Since 2014, I have reviewed over 50 manuscripts for various prestigious biomedical journals. These include "Frontiers in Immunology," "Autoimmunity," "Protein Science," "World Journal of Gastroenterology," "Journal of Genetics and Genomics," "World Journal of Hepatology," "Journal of Cell Science," "Immunologic Research," "Scandinavian Journal of Immunology," "Journal of Molecular Biology," "Viral Immunology," "Endocrine, Metabolic & Immune Disorders-Drug Targets," "Evidence-based Complementary and Alternative Medicine," "Yeast," and "Experimental Cell Research"​, and others. My professional goals revolve around advancing the field of immunology, with a particular focus on autoimmune diseases. I aim to contribute to the understanding and treatment of these conditions through innovative research and collaboration. My long-term research interests include investigating the potential use of CRISPR gene editing to eliminate pathogenic autoantibodies and developing novel assays for detecting autoantibody biomarkers of autoimmune diseases. This work is driven by a desire to improve patient outcomes and to explore cutting-edge scientific techniques that could revolutionize our approach to treatment and diagnosis. Speak fluently three languages and give great classes for both graduate and undergraduate students. I enjoy watching some Sci-Fi series and playing with my son.